{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36817858", "DateCompleted": {"Year": "2023", "Month": "02", "Day": "27"}, "DateRevised": {"Year": "2024", "Month": "01", "Day": "17"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "02", "Day": "09"}], "Language": ["eng"], "ELocationID": ["2507683", "10.1155/2023/2507683"], "Journal": {"ISSN": "2314-6141", "JournalIssue": {"Volume": "2023", "PubDate": {"Year": "2023"}}, "Title": "BioMed research international", "ISOAbbreviation": "Biomed Res Int"}, "ArticleTitle": "A Network Pharmacology Method Combined with Molecular Docking Verification to Explore the Therapeutic Mechanisms Underlying Simiao Pill Herbal Medicine against Hyperuricemia.", "Pagination": {"StartPage": "2507683", "MedlinePgn": "2507683"}, "Abstract": {"AbstractText": ["Hyperuricemia (HUA) is a common metabolic disease caused by disordered purine metabolism. We aim to reveal the mechanisms underlying the anti-HUA function of Simiao pill and provide therapeutic targets.", "Simiao pill-related targets were obtained using Herbal Ingredients' Targets (HIT), Traditional Chinese Medicine Systems Pharmacology (TCMSP), and Traditional Chinese Medicine Integrated Database (TCMID). HUA-associated targets were retrieved from GeneCards, DisGeNET, and Therapeutic Targets Database (TTD). Protein-protein interaction (PPI) network was constructed using the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) database, ggraph and igraph R packages. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed using ClusterProfiler. The top 10 core targets were identified through cytoHubba. Molecular docking was conducted using PyMOL and AutoDock high-performance liquid chromatograph (HPLC) analysis was performed to identify effective compounds of Simiao pill.", "Simiao pill-HUA target network contained 80 targets. The key targets were mainly involved in inflammatory responses. Insulin (INS), tumor necrosis factor (TNF), interleukin-6 (IL6), interleukin 1 beta (IL1B), vascular endothelial growth factor A (VEGFA), leptin (LEP), signal transducer and activator of transcription 3 (STAT3), C-C motif chemokine ligand 2 (CCL2), interleukin-10 (IL10), and toll like receptor 4 (TLR4) were the top 10 targets in the PPI network. GO analysis demonstrated the main implication of the targets in molecular responses, production, and metabolism. KEGG analysis revealed that Simiao pill might mitigate HUA through advanced glycation end-product- (AGE-) receptor for AGE- (RAGE-) and hypoxia-inducible factor-1- (HIF-1-) associated pathways. IL1B, IL6, IL10, TLR4, and TNF were finally determined as the promising targets of Simiao pill treating HUA. Through molecular docking and HPLC analysis, luteolin, quercetin, rutaecarpine, baicalin, and atractylenolide I were the main active compounds.", "Simiao pill can mitigate HUA by restraining inflammation, mediating AGE-RAGE- and HIF-1-related pathways, and targeting IL1B, IL6, IL10, TLR4, and TNF."], "CopyrightInformation": "Copyright \u00a9 2023 Yue Qian et al."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Rehabilitation Center, Hangzhou Wuyunshan Hospital (Hangzhou Institute of Health Promotion), Hangzhou 310000, China."}], "LastName": "Qian", "ForeName": "Yue", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nephrology, Hangzhou TCM Hospital of Zhejiang Chinese Medical University (Hangzhou Hospital of Traditional Chinese Medicine), Hangzhou 310000, China."}], "LastName": "Yin", "ForeName": "Jiazhen", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Rehabilitation Center, Hangzhou Wuyunshan Hospital (Hangzhou Institute of Health Promotion), Hangzhou 310000, China."}], "LastName": "Ni", "ForeName": "Juemin", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Rehabilitation Center, Hangzhou Wuyunshan Hospital (Hangzhou Institute of Health Promotion), Hangzhou 310000, China."}], "LastName": "Chen", "ForeName": "Xiaona", "Initials": "X"}, {"Identifier": ["0000-0002-3676-6345"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nursing, Hangzhou Wuyunshan Hospital (Hangzhou Institute of Health Promotion), Hangzhou 310000, China."}], "LastName": "Shen", "ForeName": "Yan", "Initials": "Y"}], "PublicationTypeList": ["Journal Article", "Retracted Publication"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Biomed Res Int", "NlmUniqueID": "101600173"}, "ChemicalList": [{"RegistryNumber": "130068-27-8", "NameOfSubstance": "Interleukin-10"}, {"RegistryNumber": "0", "NameOfSubstance": "Toll-Like Receptor 4"}, {"RegistryNumber": "0", "NameOfSubstance": "Vascular Endothelial Growth Factor A"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-6"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Necrosis Factor-alpha"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}], "CommentsCorrectionsList": [{"RefSource": "Biomed Res Int. 2024 Jan 9;2024:9754274. doi: 10.1155/2024/9754274", "PMID": "38230078"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Interleukin-10"}, {"QualifierName": [], "DescriptorName": "Network Pharmacology"}, {"QualifierName": [], "DescriptorName": "Toll-Like Receptor 4"}, {"QualifierName": [], "DescriptorName": "Vascular Endothelial Growth Factor A"}, {"QualifierName": [], "DescriptorName": "Hyperuricemia"}, {"QualifierName": [], "DescriptorName": "Interleukin-6"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Tumor Necrosis Factor-alpha"}, {"QualifierName": [], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": [], "DescriptorName": "Medicine, Chinese Traditional"}], "CoiStatement": "The authors declare that there is no conflict of interest regarding the publication of this paper."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Yang W. X., Ma Y., Hou Y. L., Wang Y. B., You C. G. Prevalence of hyperuricemia and its correlation with serum lipids and blood glucose in physical examination population in 2015-2018: a retrospective study. Clinical Laboratory . 2019;65 doi: 10.7754/Clin.Lab.2019.190338.", "ArticleIdList": ["10.7754/Clin.Lab.2019.190338", "31414762"]}, {"Citation": "Hou C., Hu Y., Jiang H., et al. Establishment of a 3D hyperuricemia model based on cultured human liver organoids. Free Radical Biology & Medicine . 2022;178:7\u201317. doi: 10.1016/j.freeradbiomed.2021.11.023.", "ArticleIdList": ["10.1016/j.freeradbiomed.2021.11.023", "34823017"]}, {"Citation": "Nutmakul T. A review on benefits of quercetin in hyperuricemia and gouty arthritis. Saudi Pharmaceutical Journal . 2022;30(7):918\u2013926. doi: 10.1016/j.jsps.2022.04.013.", "ArticleIdList": ["10.1016/j.jsps.2022.04.013", "PMC9315272", "35903522"]}, {"Citation": "Zhu Y., Peng X., Ling G. An update on the animal models in hyperuricaemia research. Clinical and Experimental Rheumatology . 2017;35(5):860\u2013864.", "ArticleIdList": ["28516889"]}, {"Citation": "George C., Minter D. A. Hyperuricemia . Treasure Island (FL): StatPearls Publishing LLC; 2022.", "ArticleIdList": ["29083565"]}, {"Citation": "Nakamura M., Fujita K., Toyoda Y., Takada T., Hasegawa H., Ichida K. Investigation of the transport of xanthine dehydrogenase inhibitors by the urate transporter ABCG2. Drug Metabolism and Pharmacokinetics . 2018;33(1):77\u201381. doi: 10.1016/j.dmpk.2017.11.002.", "ArticleIdList": ["10.1016/j.dmpk.2017.11.002", "29342419"]}, {"Citation": "Liu F., Du G. L., Song N., et al. Hyperuricemia and its association with adiposity and dyslipidemia in Northwest China: results from cardiovascular risk survey in Xinjiang (CRS 2008-2012) Lipids in Health and Disease . 2020;19(1):p. 58. doi: 10.1186/s12944-020-01211-z.", "ArticleIdList": ["10.1186/s12944-020-01211-z", "PMC7115071", "32238146"]}, {"Citation": "Si K., Wei C., Xu L., et al. Hyperuricemia and the risk of heart failure: pathophysiology and therapeutic implications. Frontiers in Endocrinology . 2021;12, article 770815 doi: 10.3389/fendo.2021.770815.", "ArticleIdList": ["10.3389/fendo.2021.770815", "PMC8633872", "34867815"]}, {"Citation": "Riaz M., Al Kury L. T., Atzaz N., et al. Carvacrol alleviates hyperuricemia-induced oxidative stress and inflammation by modulating the NLRP3/NF-\u03baB pathwayt. Drug Design, Development and Therapy . 2022;16:1159\u20131170. doi: 10.2147/DDDT.S343978.", "ArticleIdList": ["10.2147/DDDT.S343978", "PMC9041362", "35496367"]}, {"Citation": "Pramar Y. V., Mandal T. K., Bostanian L. A., Le G., Morris T. C., Graves R. A. Physicochemical stability of compounded allopurinol suspensions in PCCA Base, SuspendIt. International Journal of Pharmaceutical Compounding . 2020;24(5):413\u2013419.", "ArticleIdList": ["PMC8603380", "32886640"]}, {"Citation": "Gerriets V., Jialal I. Febuxostat . Treasure Island (FL): StatPearls Publishing LLC; 2022.", "ArticleIdList": ["31334959"]}, {"Citation": "Cicero A. F. G., Fogacci F., Kuwabara M., Borghi C. Therapeutic strategies for the treatment of chronic hyperuricemia: an evidence-based update. Medicina . 2021;57(1)", "ArticleIdList": ["PMC7827966", "33435164"]}, {"Citation": "Ullah R., Alqahtani A. S. GC-MS analysis, heavy metals, biological, and toxicological evaluation of Reseda muricata and Marrubium vulgare methanol extracts. Evidence-Based Complementary and Alternative Medicine . 2022;2022:9. doi: 10.1155/2022/2284328.2284328", "ArticleIdList": ["10.1155/2022/2284328", "PMC8959963", "35356243"]}, {"Citation": "Liu P., Xu H., Shi Y., Deng L., Chen X. Potential molecular mechanisms of plantain in the treatment of gout and hyperuricemia based on network pharmacology. Evidence-Based Complementary and Alternative Medicine . 2020;2020:20. doi: 10.1155/2020/3023127.3023127", "ArticleIdList": ["10.1155/2020/3023127", "PMC7603577", "33149752"]}, {"Citation": "Huang H. C., Kuo H. C., Yu H. R., et al. Profile of urinary cytokines in Kawasaki disease: non-invasive markers. Diagnostics . 2021;11(10):p. 1857. doi: 10.3390/diagnostics11101857.", "ArticleIdList": ["10.3390/diagnostics11101857", "PMC8534454", "34679555"]}, {"Citation": "Chen Y., Zhu L., Hu W., Wang Y., Wen X., Yang J. Simiao Wan modulates the gut microbiota and bile acid metabolism during improving type 2 diabetes mellitus in mice. Phytomedicine . 2022;104, article 154264 doi: 10.1016/j.phymed.2022.154264.", "ArticleIdList": ["10.1016/j.phymed.2022.154264", "35752076"]}, {"Citation": "Jiang Q. X., Chen Y. M., Ma J. J., et al. Effective fraction from Simiao Wan prevents hepatic insulin resistant by inhibition of lipolysis via AMPK activation. Chinese Journal of Natural Medicines . 2022;20(3):161\u2013176. doi: 10.1016/S1875-5364(21)60115-2.", "ArticleIdList": ["10.1016/S1875-5364(21)60115-2", "35369960"]}, {"Citation": "Tang M., Xie X., Yi P., et al. Integrating network pharmacology with molecular docking to unravel the active compounds and potential mechanism of Simiao pill treating rheumatoid arthritis. Evidence-Based Complementary and Alternative Medicine . 2020;2020:16. doi: 10.1155/2020/5786053.5786053", "ArticleIdList": ["10.1155/2020/5786053", "PMC7657688", "33204288"]}, {"Citation": "Ullah M., Mehmood S., Khan R. A., et al. Assessment of antidiabetic potential and phytochemical profiling of Viscum album, a traditional antidiabetic plant. Journal of Food Quality . 2022;2022:9. doi: 10.1155/2022/5691379.5691379", "ArticleIdList": ["10.1155/2022/5691379"]}, {"Citation": "Sarker U., Oba S., Ercisli S., Assouguem A., Alotaibi A., Ullah R. Bioactive phytochemicals and quenching activity of radicals in selected drought-resistant Amaranthus tricolor vegetable amaranth. Antioxidants . 2022;11(3):p. 578. doi: 10.3390/antiox11030578.", "ArticleIdList": ["10.3390/antiox11030578", "PMC8944989", "35326227"]}, {"Citation": "Zeng L., Deng Y., Chen J., et al. Exploring the therapeutic mechanism of Simiao pills for hyperuricemia based on network pharmacology and molecular docking. Journal of Southern Medical University . 2021;41(4):579\u2013587. doi: 10.12122/j.issn.1673-4254.2021.04.15.", "ArticleIdList": ["10.12122/j.issn.1673-4254.2021.04.15", "PMC8110457", "33963719"]}, {"Citation": "Shen P., Tu S., Wang H., Qin K., Chen Z. Simiao pill attenuates collagen-induced arthritis in rats through suppressing the ATX-LPA and MAPK signalling pathways. Evidence-Based Complementary and Alternative Medicine . 2019;2019:11. doi: 10.1155/2019/7498527.7498527", "ArticleIdList": ["10.1155/2019/7498527", "PMC6437962", "31001354"]}, {"Citation": "Li S., Liu D., Chen Z., et al. Comparative efficacy and safety of four classical prescriptions for clearing damp-heat recommended by clinical guidelines in treating rheumatoid arthritis: a network meta-analysis. Annals of Palliative Medicine . 2021;10(7):7298\u20137328. doi: 10.21037/apm-21-445.", "ArticleIdList": ["10.21037/apm-21-445", "34353032"]}, {"Citation": "Shan B., Chen T., Huang B., Liu Y., Chen J. Untargeted metabolomics reveal the therapeutic effects of Ermiao wan categorized formulas on rats with hyperuricemia. Journal of Ethnopharmacology . 2021;281, article 114545 doi: 10.1016/j.jep.2021.114545.", "ArticleIdList": ["10.1016/j.jep.2021.114545", "34419610"]}, {"Citation": "Wang L., Xiong F., Zhao S., Yang Y., Zhou G. Network pharmacology combined with molecular docking to explore the potential mechanisms for the antioxidant activity of Rheum tanguticum seeds. BMC Complementary Medicine and Therapies . 2022;22(1):p. 121. doi: 10.1186/s12906-022-03611-3.", "ArticleIdList": ["10.1186/s12906-022-03611-3", "PMC9066831", "35505340"]}, {"Citation": "Xu L., Zhang J., Wang Y., Zhang Z., Wang F., Tang X. Uncovering the mechanism of Ge-Gen-Qin-Lian decoction for treating ulcerative colitis based on network pharmacology and molecular docking verification. Bioscience Reports . 2021;41(2) doi: 10.1042/BSR20203565.", "ArticleIdList": ["10.1042/BSR20203565", "PMC7876598", "33409535"]}, {"Citation": "Yan D., Zheng G., Wang C., et al. HIT 2.0: an enhanced platform for Herbal Ingredients' Targets. Nucleic Acids Research . 2022;50(D1):D1238\u2013D1243. doi: 10.1093/nar/gkab1011.", "ArticleIdList": ["10.1093/nar/gkab1011", "PMC8728248", "34986599"]}, {"Citation": "Zhang W., Lv M., Shi Y., Mu Y., Yao Z., Yang Z. Network pharmacology-based study of the underlying mechanisms of Huangqi Sijunzi decoction for Alzheimer\u2019s disease. Evidence-Based Complementary and Alternative Medicine . 2021;2021:13. doi: 10.1155/2021/6480381.6480381", "ArticleIdList": ["10.1155/2021/6480381", "PMC8510793", "34650613"]}, {"Citation": "Huang L., Xie D., Yu Y., et al. TCMID 2.0: a comprehensive resource for TCM. Nucleic Acids Research . 2018;46(D1):D1117\u2013D1120. doi: 10.1093/nar/gkx1028.", "ArticleIdList": ["10.1093/nar/gkx1028", "PMC5753259", "29106634"]}, {"Citation": "Kim S., Thiessen P. A., Bolton E. E., et al. PubChem substance and compound databases. Nucleic Acids Research . 2016;44(D1):D1202\u2013D1213. doi: 10.1093/nar/gkv951.", "ArticleIdList": ["10.1093/nar/gkv951", "PMC4702940", "26400175"]}, {"Citation": "Ahire D., Kruger L., Sharma S., Mettu V. S., Basit A., Prasad B. Quantitative proteomics in translational absorption, distribution, metabolism, and excretion and precision medicine. Pharmacological Reviews . 2022;74(3):769\u2013796. doi: 10.1124/pharmrev.121.000449.", "ArticleIdList": ["10.1124/pharmrev.121.000449", "PMC9553121", "35738681"]}, {"Citation": "Galm\u00e9s S., Reyn\u00e9s B., Palou M., Palou-March A., Palou A. Absorption, distribution, metabolism, and excretion of the main olive tree phenols and polyphenols: a literature review. Journal of Agricultural and Food Chemistry . 2021;69(18):5281\u20135296. doi: 10.1021/acs.jafc.1c00737.", "ArticleIdList": ["10.1021/acs.jafc.1c00737", "33908772"]}, {"Citation": "Bickerton G. R., Paolini G. V., Besnard J., Muresan S., Hopkins A. L. Quantifying the chemical beauty of drugs. Nature Chemistry . 2012;4(2):90\u201398. doi: 10.1038/nchem.1243.", "ArticleIdList": ["10.1038/nchem.1243", "PMC3524573", "22270643"]}, {"Citation": "UniProt Consortium. UniProt: a hub for protein information. Nucleic Acids Research . 2015;43", "ArticleIdList": ["PMC4384041", "25348405"]}, {"Citation": "Safran M., Dalah I., Alexander J., et al. GeneCards version 3: the human gene integrator. Database: the Journal of Biological Databases and Curation . 2010;2010 doi: 10.1093/database/baq020.", "ArticleIdList": ["10.1093/database/baq020", "PMC2938269", "20689021"]}, {"Citation": "Pi\u00f1ero J., Ram\u00edrez-Anguita J. M., Sa\u00fcch-Pitarch J., et al. The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Research . 2020;48(D1):D845\u2013D855. doi: 10.1093/nar/gkz1021.", "ArticleIdList": ["10.1093/nar/gkz1021", "PMC7145631", "31680165"]}, {"Citation": "Zhou Y., Zhang Y., Lian X., et al. Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents. Nucleic Acids Research . 2022;50(D1):D1398\u2013D1407. doi: 10.1093/nar/gkab953.", "ArticleIdList": ["10.1093/nar/gkab953", "PMC8728281", "34718717"]}, {"Citation": "Zhou Z., Li Y., Hao H., et al. Screening hub genes as prognostic biomarkers of hepatocellular carcinoma by bioinformatics analysis. Cell Transplantation . 2019;28(1_supplement):76s\u201386s. doi: 10.1177/0963689719893950.", "ArticleIdList": ["10.1177/0963689719893950", "PMC7016461", "31822116"]}, {"Citation": "Zhou Y., Zhou B., Pache L., et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nature Communications . 2019;10(1):p. 1523. doi: 10.1038/s41467-019-09234-6.", "ArticleIdList": ["10.1038/s41467-019-09234-6", "PMC6447622", "30944313"]}, {"Citation": "Wu T., Hu E., Xu S., et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. The innovation . 2021;2(3, article 100141) doi: 10.1016/j.xinn.2021.100141.", "ArticleIdList": ["10.1016/j.xinn.2021.100141", "PMC8454663", "34557778"]}, {"Citation": "Yang M., Chen J., Xu L., et al. A network pharmacology approach to uncover the molecular mechanisms of herbal formula Ban-Xia-Xie-Xin-Tang. Evidence-Based Complementary and Alternative Medicine . 2018;2018:22. doi: 10.1155/2018/4050714.4050714", "ArticleIdList": ["10.1155/2018/4050714", "PMC6206573", "30410554"]}, {"Citation": "Murad H. A. S., Alqurashi T. M. A., Hussien M. A. Interactions of selected cardiovascular active natural compounds with CXCR4 and CXCR7 receptors: a molecular docking, molecular dynamics, and pharmacokinetic/toxicity prediction study. BMC Complementary Medicine and Therapies . 2022;22(1):p. 35. doi: 10.1186/s12906-021-03488-8.", "ArticleIdList": ["10.1186/s12906-021-03488-8", "PMC8817505", "35120520"]}, {"Citation": "Sterling T., Irwin J. J. ZINC 15 \u2013 ligand discovery for everyone. Journal of Chemical Information and Modeling . 2015;55(11):2324\u20132337. doi: 10.1021/acs.jcim.5b00559.", "ArticleIdList": ["10.1021/acs.jcim.5b00559", "PMC4658288", "26479676"]}, {"Citation": "Feng C., Zhao M., Jiang L., Hu Z., Fan X. Mechanism of modified Danggui Sini Decoction for knee osteoarthritis based on network pharmacology and molecular docking. Evidence-Based Complementary and Alternative Medicine . 2021;2021:11. doi: 10.1155/2021/6680637.6680637", "ArticleIdList": ["10.1155/2021/6680637", "PMC7895562", "33628311"]}, {"Citation": "Pinzi L., Rastelli G. Molecular docking: shifting paradigms in drug discovery. International Journal of Molecular Sciences . 2019;20(18):p. 4331. doi: 10.3390/ijms20184331.", "ArticleIdList": ["10.3390/ijms20184331", "PMC6769923", "31487867"]}, {"Citation": "Sun Z. R., Liu H. R., Hu D., et al. Ellagic acid exerts beneficial effects on hyperuricemia by inhibiting xanthine oxidase and NLRP3 inflammasome activation. Journal of Agricultural and Food Chemistry . 2021;69(43):12741\u201312752. doi: 10.1021/acs.jafc.1c05239.", "ArticleIdList": ["10.1021/acs.jafc.1c05239", "34672194"]}, {"Citation": "Huang B., Hu X., Wang J., Li P., Chen J. Study on chemical constituents of herbal formula Er Miao Wan and GC-MS based metabolomics approach to evaluate its therapeutic effects on hyperuricemic rats. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences . 2019;1118-1119:101\u2013108. doi: 10.1016/j.jchromb.2019.04.032.", "ArticleIdList": ["10.1016/j.jchromb.2019.04.032", "31030102"]}, {"Citation": "Gao Y., Sun J., Zhang Y., et al. Effect of a traditional Chinese medicine formula (CoTOL) on serum uric acid and intestinal flora in obese hyperuricemic mice inoculated with intestinal bacteria. Evidence-Based Complementary and Alternative Medicine . 2020;2020:10. doi: 10.1155/2020/8831937.8831937", "ArticleIdList": ["10.1155/2020/8831937", "PMC7775141", "33424995"]}, {"Citation": "Fan Y., Liu W., Jin Y., et al. Integrated molecular docking with network pharmacology to reveal the molecular mechanism of Simiao powder in the treatment of acute gouty arthritis. Evidence-Based Complementary and Alternative Medicine . 2021;2021:15. doi: 10.1155/2021/5570968.5570968", "ArticleIdList": ["10.1155/2021/5570968", "PMC8100412", "34007291"]}, {"Citation": "Hu Q. H., Jiao R. Q., Wang X., Lv Y. Z., Kong L. D. Corrigendum to \"Simiao pill ameliorates urate underexcretion and renal dysfunction in hyperuricemic mice\" [J. Ethnopharmacol. 128 (2010) 685-692] Journal of Ethnopharmacology . 2022;287, article 114966", "ArticleIdList": ["35000829"]}, {"Citation": "Zhang Y. Z., Sui X. L., Xu Y. P., Gu F. J., Zhang A. S., Chen J. H. Association between Nod-like receptor protein 3 inflammasome and gouty nephropathy. Experimental and Therapeutic Medicine . 2020;20(1):195\u2013204. doi: 10.3892/etm.2020.8694.", "ArticleIdList": ["10.3892/etm.2020.8694", "PMC7281944", "32536991"]}, {"Citation": "Zhao L., Li Y., Yao D., et al. Pharmacological basis for use of a novel compound in hyperuricemia: anti-hyperuricemic and anti-inflammatory effects. Frontiers in Pharmacology . 2021;12, article 772504 doi: 10.3389/fphar.2021.772504.", "ArticleIdList": ["10.3389/fphar.2021.772504", "PMC8607230", "34819865"]}, {"Citation": "Ye C., Huang X., Wang R., Halimulati M., Aihemaitijiang S., Zhang Z. Dietary inflammatory index and the risk of hyperuricemia: a cross-sectional study in Chinese adult residents. Nutrients . 2021;13(12):p. 4504. doi: 10.3390/nu13124504.", "ArticleIdList": ["10.3390/nu13124504", "PMC8708184", "34960057"]}, {"Citation": "Wang K., Hu L., Chen J. K. RIP3-deficience attenuates potassium oxonate-induced hyperuricemia and kidney injury. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie . 2018;101:617\u2013626. doi: 10.1016/j.biopha.2018.02.010.", "ArticleIdList": ["10.1016/j.biopha.2018.02.010", "29518608"]}, {"Citation": "Lin G., Yu Q., Xu L., et al. Berberrubine attenuates potassium oxonate- and hypoxanthine-induced hyperuricemia by regulating urate transporters and JAK2/STAT3 signaling pathway. European Journal of Pharmacology . 2021;912, article 174592 doi: 10.1016/j.ejphar.2021.174592.", "ArticleIdList": ["10.1016/j.ejphar.2021.174592", "34699754"]}, {"Citation": "Ren Q., Wang B., Guo F., et al. Natural flavonoid pectolinarigenin alleviated hyperuricemic nephropathy via suppressing TGF\u03b2/SMAD3 and JAK2/STAT3 signaling pathways. Frontiers in pharmacology. . 2022;12, article 792139 doi: 10.3389/fphar.2021.792139.", "ArticleIdList": ["10.3389/fphar.2021.792139", "PMC8829971", "35153751"]}, {"Citation": "Han J., Wang X., Tang S., et al. Protective effects of tuna meat oligopeptides (TMOP) supplementation on hyperuricemia and associated renal inflammation mediated by gut microbiota. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. . 2020;34(4):5061\u20135076. doi: 10.1096/fj.201902597RR.", "ArticleIdList": ["10.1096/fj.201902597RR", "32043638"]}, {"Citation": "Said M. A., Nafeh N. Y., Abdallah H. A. Spexin alleviates hypertension, hyperuricaemia, dyslipidemia and insulin resistance in high fructose diet induced metabolic syndrome in rats via enhancing PPAR-\u0263 and AMPK and inhibiting IL-6 and TNF-\u03b1. Archives of Physiology and Biochemistry . 2021;1-6:1\u20136. doi: 10.1080/13813455.2021.1899242.", "ArticleIdList": ["10.1080/13813455.2021.1899242", "33721543"]}, {"Citation": "Eckenstaler R., Benndorf R. A. The role of ABCG2 in the pathogenesis of primary hyperuricemia and gout-an update. International Journal of Molecular Sciences . 2021;22(13):p. 6678. doi: 10.3390/ijms22136678.", "ArticleIdList": ["10.3390/ijms22136678", "PMC8268734", "34206432"]}, {"Citation": "Lu Y. H., Chang Y. P., Li T., et al. Empagliflozin attenuates hyperuricemia by upregulation of ABCG2 via AMPK/AKT/CREB signaling pathway in type 2 diabetic mice. International Journal of Biological Sciences . 2020;16(3):529\u2013542. doi: 10.7150/ijbs.33007.", "ArticleIdList": ["10.7150/ijbs.33007", "PMC6990905", "32015688"]}, {"Citation": "Qin N., Jiang Y., Shi W., et al. High-throughput untargeted serum metabolomics analysis of hyperuricemia patients by UPLC-Q-TOF/MS. Evidence-Based Complementary and Alternative Medicine . 2021;2021:15. doi: 10.1155/2021/5524772.5524772", "ArticleIdList": ["10.1155/2021/5524772", "PMC8216829", "34234835"]}, {"Citation": "Kl\u00fcck V., Liu R., Joosten L. A. B. The role of interleukin-1 family members in hyperuricemia and gout. Joint, Bone, Spine . 2021;88(2, article 105092) doi: 10.1016/j.jbspin.2020.105092.", "ArticleIdList": ["10.1016/j.jbspin.2020.105092", "33129923"]}, {"Citation": "Li S., Li L., Yan H., et al. Anti-gouty arthritis and anti-hyperuricemia properties of celery seed extracts in rodent models. Molecular Medicine Reports . 2019;20(5):4623\u20134633. doi: 10.3892/mmr.2019.10708.", "ArticleIdList": ["10.3892/mmr.2019.10708", "PMC6797962", "31702020"]}, {"Citation": "Ahmadieh H., Azar S. Effects of sodium glucose cotransporter-2 inhibitors on serum uric acid in type 2 diabetes mellitus. Diabetes Technology & Therapeutics . 2017;19(9):507\u2013512. doi: 10.1089/dia.2017.0070.", "ArticleIdList": ["10.1089/dia.2017.0070", "28749169"]}, {"Citation": "Katsiki N., Dimitriadis G. D., Mikhailidis D. P. Serum uric acid and diabetes: from pathophysiology to cardiovascular disease. Current Pharmaceutical Design . 2021;27(16):1941\u20131951. doi: 10.2174/1381612827666210104124320.", "ArticleIdList": ["10.2174/1381612827666210104124320", "33397230"]}, {"Citation": "Adachi S. I., Yoshizawa F., Yagasaki K. Hyperuricemia in type 2 diabetic model KK-A (y)/Ta mice: a potent animal model with positive correlation between insulin resistance and plasma high uric acid levels. BMC Research Notes . 2017;10(1):p. 577. doi: 10.1186/s13104-017-2897-x.", "ArticleIdList": ["10.1186/s13104-017-2897-x", "PMC5678565", "29115981"]}, {"Citation": "Muthyalaiah Y. S., Jonnalagadda B., John C. M., Arockiasamy S. Impact of advanced glycation end products (AGEs) and its receptor (RAGE) on cancer metabolic signaling pathways and its progression. Glycoconjugate Journal . 2021;38(6):717\u2013734. doi: 10.1007/s10719-021-10031-x.", "ArticleIdList": ["10.1007/s10719-021-10031-x", "35064413"]}, {"Citation": "Sukjamnong S., Chen H., Saad S., Santiyanont R. Fimbristylis ovata and Artemisia vulgaris extracts inhibited AGE-mediated RAGE expression, ROS generation, and inflammation in THP-1 cells. Toxicological Research . 2022;38(3):331\u2013343. doi: 10.1007/s43188-021-00114-0.", "ArticleIdList": ["10.1007/s43188-021-00114-0", "PMC9247136", "35874499"]}, {"Citation": "Jain T., Nikolopoulou E. A., Xu Q., Qu A. Hypoxia inducible factor as a therapeutic target for atherosclerosis. Pharmacology & Therapeutics . 2018;183:22\u201333. doi: 10.1016/j.pharmthera.2017.09.003.", "ArticleIdList": ["10.1016/j.pharmthera.2017.09.003", "28942242"]}, {"Citation": "Gao X., Li Y., Wang H., Li C., Ding J. Inhibition of HIF-1\u03b1 decreases expression of pro-inflammatory IL-6 and TNF-\u03b1 in diabetic retinopathy. Acta Ophthalmologica . 2017;95(8):e746\u2013e750. doi: 10.1111/aos.13096.", "ArticleIdList": ["10.1111/aos.13096", "27288252"]}, {"Citation": "Conti P., Caraffa A., Gallenga C. E., et al. Powerful anti-inflammatory action of luteolin: potential increase with IL-38. BioFactors . 2021;47(2):165\u2013169. doi: 10.1002/biof.1718.", "ArticleIdList": ["10.1002/biof.1718", "33755250"]}, {"Citation": "Xie T., Yuan J., Mei L., Li P., Pan R. Luteolin suppresses TNF-\u03b1-induced inflammatory injury and senescence of nucleus pulposus cells via the Sirt 6/NF-\u03baB pathway. Experimental and Therapeutic Medicine . 2022;24(1):p. 469. doi: 10.3892/etm.2022.11396.", "ArticleIdList": ["10.3892/etm.2022.11396", "PMC9204575", "35747154"]}, {"Citation": "Jayakumar T., Lin K. C., Chang C. C., et al. Targeting MAPK/NF-\u03baB pathways in anti-inflammatory potential of rutaecarpine: impact on Src/FAK-mediated macrophage migration. International Journal of Molecular Sciences . 2022;23(1):p. 92. doi: 10.3390/ijms23010092.", "ArticleIdList": ["10.3390/ijms23010092", "PMC8745017", "35008520"]}, {"Citation": "Yan L., Li Q. F., Rong Y. T., et al. The protective effects of rutaecarpine on acute pancreatitis. Oncology Letters . 2018;15(3):3121\u20133126. doi: 10.3892/ol.2017.7659.", "ArticleIdList": ["10.3892/ol.2017.7659", "PMC5778859", "29435045"]}, {"Citation": "Ren S., Wei Y., Wang R., et al. Rutaecarpine ameliorates ethanol-induced gastric mucosal injury in mice by modulating genes related to inflammation, oxidative stress and apoptosis. Frontiers in Pharmacology . 2020;11, article 600295 doi: 10.3389/fphar.2020.600295.", "ArticleIdList": ["10.3389/fphar.2020.600295", "PMC7726440", "33324227"]}, {"Citation": "Huang H., Wang M., Guo Z., et al. Rutaecarpine alleviates acute pancreatitis in mice and AR42J cells by suppressing the MAPK and NF-\u03baB signaling pathways via calcitonin gene-related peptide. Phytotherapy Research . 2021;35(11):6472\u20136485. doi: 10.1002/ptr.7301.", "ArticleIdList": ["10.1002/ptr.7301", "34661951"]}, {"Citation": "Guo L. T., Wang S. Q., Su J., et al. Baicalin ameliorates neuroinflammation-induced depressive-like behavior through inhibition of toll-like receptor 4 expression via the PI3K/AKT/FoxO1 pathway. Journal of Neuroinflammation . 2019;16(1):p. 95. doi: 10.1186/s12974-019-1474-8.", "ArticleIdList": ["10.1186/s12974-019-1474-8", "PMC6507025", "31068207"]}, {"Citation": "Zhu L., Shen H., Gu P. Q., Liu Y. J., Zhang L., Cheng J. F. Baicalin alleviates TNBS-induced colitis by inhibiting PI3K/AKT pathway activation. Experimental and Therapeutic Medicine . 2020;20(1):581\u2013590. doi: 10.3892/etm.2020.8718.", "ArticleIdList": ["10.3892/etm.2020.8718", "PMC7281943", "32537016"]}, {"Citation": "Di Petrillo A., Orr\u00f9 G., Fais A., Fantini M. C. Quercetin and its derivates as antiviral potentials: a comprehensive review. Phytotherapy Research . 2022;36(1):266\u2013278. doi: 10.1002/ptr.7309.", "ArticleIdList": ["10.1002/ptr.7309", "PMC8662201", "34709675"]}, {"Citation": "Li Y., Wang Y., Liu Z., Guo X., Miao Z., Ma S. Atractylenolide I induces apoptosis and suppresses glycolysis by blocking the JAK2/STAT3 signaling pathway in colorectal cancer cells. Frontiers in Pharmacology . 2020;11:p. 273. doi: 10.3389/fphar.2020.00273.", "ArticleIdList": ["10.3389/fphar.2020.00273", "PMC7114890", "32273843"]}, {"Citation": "Du Z., Ma Z., Lai S., et al. Atractylenolide I ameliorates acetaminophen-induced acute liver injury via the TLR4/MAPKs/NF-\u03baB signaling pathways. Frontiers in Pharmacology . 2022;13, article 797499 doi: 10.3389/fphar.2022.797499.", "ArticleIdList": ["10.3389/fphar.2022.797499", "PMC8815859", "35126160"]}, {"Citation": "Li C., Wang C., Guo Y., et al. Research on the effect and underlying molecular mechanism of Cangzhu in the treatment of gouty arthritis. European Journal of Pharmacology . 2022;927, article 175044 doi: 10.1016/j.ejphar.2022.175044.", "ArticleIdList": ["10.1016/j.ejphar.2022.175044", "35643303"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "9", "Day": "7"}, {"Year": "2022", "Month": "10", "Day": "17"}, {"Year": "2022", "Month": "10", "Day": "19"}, {"Year": "2023", "Month": "2", "Day": "23", "Hour": "9", "Minute": "42"}, {"Year": "2023", "Month": "2", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "3", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "2", "Day": "9"}], "PublicationStatus": "epublish", "ArticleIdList": ["36817858", "PMC9935928", "10.1155/2023/2507683"]}}], "PubmedBookArticle": []}